Compass Pathways Plc (CMPS)
5.55
-0.20
(-3.48%)
USD |
NASDAQ |
Apr 07, 16:00
5.60
+0.05
(+0.90%)
After-Hours: 19:44
Compass Pathways EPS Diluted (Quarterly) : -1.001 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Silence Therapeutics Plc | -0.0831 |
| Adaptimmune Therapeutics Plc | -0.1163 |
| Biodexa Pharmaceuticals Plc | -- |
| Oxford Biomedica Plc | -- |
| NuCana Plc | -0.7979 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -93.74M |
| Total Expenses (Quarterly) | 93.74M |
| Enterprise Value | 626.36M |
| Earnings Yield | -55.41% |
| Normalized Earnings Yield | -39.26 |